A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2-microglobulin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2-microglobulin

Published:2014-09-19 Issue:2 Volume:168 Page:239-245
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Melchardt Thomas¹,Troppan Katharina²,Weiss Lukas¹,Hufnagl Clemens¹,Neureiter Daniel³,Tränkenschuh Wolfgang³,Hopfinger Georg¹,Magnes Teresa¹,Deutsch Alexander²,Neumeister Peter²,Hackl Hubert⁴,Greil Richard¹,Pichler Martin⁵,Egle Alexander¹

Affiliation:

1. Department of Internal Medicine III; Paracelsus Medical University Salzburg; Salzburg Austria

2. Division of Haematology; Medical University of Graz; Graz Austria

3. Institute of Pathology; Paracelsus Medical University Salzburg; Salzburg

4. Division of Bioinformatics; Biocentre; Medical University of Innsbruck; Innsbruck Austria

5. Department of Experimental Therapeutics; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13116/fullpdf

Reference14 articles.

1. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper;Aapro;Annals of Oncology,2011

2. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma;Cowan;British Journal of Cancer,1989

3. Non-pegylated liposomal encapsulated doxorubicin reduces cardiotoxicity in 1st line treatment of diffuse large B-cell lymphoma (DLBCL). Final results of a randomized trial;Fridrik;Blood,2011

4. Concordance probability and discriminatory power in proportional hazards regression;Gönen;Biometrika,2005

5. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy;Gutierrez-Garcia;Blood,2011

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma;Cancer Medicine;2024-06

2. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma;Clinical and Experimental Medicine;2024-03-30

3. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05

4. Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B‐cell lymphoma;Cancer Medicine;2023-12-22

5. Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis;Oncology in Clinical Practice;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3